Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.03 USD
Change Today +0.0025 / 7.94%
Volume 4.4M
OXIS On Other Exchanges
Symbol
Exchange
OTC US
EN Paris
Frankfurt
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

oxis international inc (OXIS) Snapshot

Open
$0.03
Previous Close
$0.03
Day High
$0.04
Day Low
$0.03
52 Week High
03/31/15 - $0.07
52 Week Low
06/3/14 - $0.0032
Market Cap
20.4M
Average Volume 10 Days
6.7M
EPS TTM
$-0.03
Shares Outstanding
599.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OXIS INTERNATIONAL INC (OXIS)

Related News

No related news articles were found.

oxis international inc (OXIS) Related Businessweek News

No Related Businessweek News Found

oxis international inc (OXIS) Details

Oxis International, Inc. is engaged in the research, development, and sale of products that counteract the harmful effects of ‘oxidative stress’ and inflammation in the United States. Its finished products and finished product candidates include therapeutic nutraceutical products, cosmeceutical products, functional foods, and functional beverages. The company also possesses intellectual property covering various proprietary compounds and formulations that might be out-licensed to biotech and pharmaceutical companies as drug candidates. It focuses on products that incorporate the amino acid naturally occurring compound, L-Ergothioneine, which is produced by microorganisms in soil and is not synthesized by humans, animals, or plants. The company, through its subsidiary, Oxis Biotech, Inc., develops and commercializes drugs of therapeutic molecules, including cannabinoids, which are focused on various cancer indications. The company was formerly known as DDI Pharmaceuticals, Inc. and changed its name to Oxis International, Inc. in 1994. Oxis International, Inc. was founded in 1965 and is headquartered in Tampa, Florida.

2 Employees
Last Reported Date: 03/31/15
Founded in 1965

oxis international inc (OXIS) Top Compensated Officers

Chairman of the Board and Chief Executive Off...
Total Annual Compensation: --
President, Chief Financial Officer, Chief Acc...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

oxis international inc (OXIS) Key Developments

OXIS International, Inc. Auditor Raises 'Going Concern' Doubt

OXIS International, Inc. filed its 10-K on Mar 31, 2015 for the period ending Dec 31, 2014. In this report its auditor, Seligson & Giannattasio, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

OXIS International, Inc. - Shareholder/Analyst Call

To update shareholders and other interested parties on corporate developments at Oxis Biotech, Inc

Oxis Biotech Inc. Provides Update for P62-ZZ Multiple Myeloma Patent Application

Oxis International, Inc. provided an update on its P62-ZZ Chemical Inhibitor and Therapeutic Potential for Multiple Myeloma patent application for shareholders and other interested parties. Multiple myeloma remains an incurable malignancy with systematic morbidity and a median survival of 3-5 years. It is the second hematological malignancy disease, characterized by aberrant proliferation of terminally differentiated plasma cells and impairment in apoptosis capacity. Due to the interactions between myeloma cells and cells of the bone marrow microenvironment, the osteolytic bone disease associated with myeloma is inextricably linked with tumor progression. High incidence of bone metastasis in multiple myeloma patients is frequently associated with severe bone pain and pathological fracture.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXIS:US $0.03 USD +0.0025

OXIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lifeway Foods Inc $20.03 USD -0.22
Monster Beverage Corp $136.91 USD -1.09
Nu Skin Enterprises Inc $58.69 USD -0.59
Estee Lauder Cos Inc/The $82.82 USD -1.10
Hain Celestial Group Inc/The $64.01 USD -1.17
View Industry Companies
 

Industry Analysis

OXIS

Industry Average

Valuation OXIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 329.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 268.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OXIS INTERNATIONAL INC, please visit oxis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.